Initiate’s Post

Second day at ISPOR EU. Plenary session focusing on Europe's preparation and readiness for EU HTAR which commences 12th Jan 2025. 25 JCAs forecast in year one. So many stakeholders collaborating to try to achieve more efficient data generation and a more homogeneous approval process. Watch this space. #ISPOR #HTA ISPOR—The Professional Society for Health Economics and Outcomes Research Carrot Recruitment The Evidence Base®

👇 New paper is published - "The COVID-19 quandemic" on the intricacies that we observe in the intersection of social dynamics and quantification of policy making for COVID-19! 🔍 Full paper: https://lnkd.in/dgjBXcA5

Genome Canada applauds the Government of Canada for the thoughtfulness shown to science, training and innovation in Federal #Budget2024. Strategic investments in science have the potential to revolutionize health, food security, the environment and the economy. Alignment across national strategies, such as the Pan-Canadian Artificial Intelligence Strategy, the National Quantum Strategy, the Biomanufacturing and Life Sciences Strategy, and the Pan-Canadian Genomics Strategy, builds Canada’s leadership in new technologies and contributes to our global competitiveness. We look forward to partnering with the government and to convening, coordinating and catalyzing with partners across the life sciences ecosystem to address big, pressing problems.   Genome British Columbia Genome AtlanticGenome Alberta Genome PrairieGénome Québec Ontario Genomics #cdnpoli https://bit.ly/3w7c6jQ

The annual international conference for ISPOR—The Professional Society for Health Economics and Outcomes Research, ISPOR 2024, is taking place May 6–8, 2024 in Atlanta, GA, USA. With the event just around the corner, here Laura Dormer highlights some of the key sessions of interest, providing insights to help you navigate the comprehensive multi-topic program. Read at The Evidence Base® #heor #healtheconomics #outcomesresearch #rwe #rwd #realworldevidence #realworlddata #marketaccess #pharma #biopharma #medicalaffairs #regulation #regulatoryaffairs #hta #healthtechnologyassessment #healthdata #healthequity #ispor24

In conversation with ISPOR poster author: Sofie Czarnota-Bojarski Our Senior Associate, Sofie Czarnota-Bojarski, delves into the intricacies of her co-authored research poster titled "Cost-Effectiveness of apixaban Compared to warfarin, dabigatran and rivaroxaban in Patients with Nonvalvular Atrial Fibrillation: Results for High-Risk Patient Subgroups Based on the Aristophanes Real-World Evidence Study" featured at #ISPOR2024. This research aims to estimate the cost-effectiveness of apixaban versus rivaroxaban, dabigatran and warfarin in high-risk non-valvular atrial fibrillation (NVAF) subpopulations from a UK perspective over a lifetime horizon using data from ARISTOPHANES. We invite you to join Sofie in a detailed exploration of the research objectives, key data drivers, and conclusions drawn from this study. To learn more about the poster please visit: https://lnkd.in/eATuDwzQ For more insights into our contributions to ISPOR—The Professional Society for Health Economics and Outcomes Research 2024 and to discover our three other posters, visit our FIECON ISPOR Portal. https://lnkd.in/eh6pvEUz Stay tuned for upcoming interviews with our other esteemed poster authors. #HEOR #ISPRO2024 #CostComparison

🚀 𝗠𝗮𝗷𝗼𝗿 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗶𝗻 𝗔𝗜-𝗕𝗮𝘀𝗲𝗱 𝗧𝗕 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻! Rayscape has been spotlighted in a groundbreaking study published in The Lancet 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵. Here's what you need to know: 🌟 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: - Evaluated 12 CAD products with 774 participants in South Africa. - XVision (now known as Rayscape) achieved high sensitivity, placing us in the 1st tier of detection power. - Products reduced the need for confirmatory testing by over 40%. 📊 𝗜𝗺𝗽𝗮𝗰𝘁𝗳𝘂𝗹 𝗥𝗲𝘀𝘂𝗹𝘁𝘀: - Supported integrating AI-based CAD products into TB screening to enhance diagnostic efficiency. - Highlighted the need for appropriate thresholds for different populations to ensure high accuracy. - Called for a global strategy to validate new CAD products and versions. 🔍 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗠𝗼𝗿𝗲 & 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝗪𝗶𝘁𝗵 𝗨𝘀: 📄 For the full study, read here: https://lnkd.in/dbZ7TJNQ 🌐 Discover our innovations: https://rayscape.ai/ South African Medical Research Council, HSRC (Human Sciences Research Council), National Institute for Communicable Diseases (NICD), Department of Health South Africa, World Health Organization South Africa, Universität Heidelberg #Rayscape #AI #Healthcare #Tuberculosis #Innovation #DigitalHealth #TopTier #DiagnosticEfficiency #EndTB

During a session today at ISPOR—The Professional Society for Health Economics and Outcomes Research annual meeting, the Stratevi team presented results from the first-ever cost-effectiveness study of a #FactorXI inhibitor.   The objective of this economic analysis was to explore the potential cost-effectiveness of #abelacimab, using the results from the #AZALEA-TIMI 71 study that were presented during a late-breaking session at the 2023 American Heart Association Scientific Sessions.   The analysis demonstrated that abelacimab, if approved, could offer significant cost savings as compared to a current standard of care anticoagulant.   #ISPORAnnual #ISPOR24 

📉 One Plus One Makes Less than Two? Silvia Balia and Rinaldo Brau from the University of Cagliari and CRENoS examine how healthcare consolidations may inadvertently impact the health outcomes of the population and presented the results during the #63rdERSAConference. Utilizing a quasi-experimental design with detailed mortality and population data from 2002 to 2018, the study analyzes mortality trends before and after LHA consolidations. 🔍Key Findings: While mortality initially declined slightly in the first year post-reform, a sustained increase was observed from the fourth year onward, a signal that cost-cutting may lead to unintended health impacts. Particularly concerning was the disparity in effects between core and peripheral municipalities, as well as between smaller and larger communities. Working-age individuals and those affected by circulatory system diseases were disproportionately impacted. For more details ➡️https://bit.ly/4f1LD8R #ESSPINproject #Research Politecnico di Milano University of Thessaly University of Eastern Finland Centrum Europejskich Studiów Regionalnych i Lokalnych EUROREG Department of Geography and Environment, LSE University of Groningen - Faculty of Spatial Sciences Kiel Institute for the World Economy Economic and Social Research Institute (ESRI) Academia de Studii Economice din București alda* - European Association for Local Democracy CRENoS Università degli Studi di Cagliari Université de Toulon Charles University

The Meeting of the MINDS, where Science and Technology meets Aging and its related Conditions. The premier longevity meeting in Africa International Longevity Summit Africa is here, you won't want to miss it if you are passionate about healthy longevity, intrigued by biological aging or eager to contribute groundbreaking advancement in this field. In the words of Simone Hampton MD, "...doing things that allow people to live healthier, longer and more fulfilling [is the best we offer humanity]." Date: 24th and 25th of October, 2024 Venue: College of Medicine, University of Lagos, Nigeria ,Idi-Araba, Lagos. Why attend? Groundbreaking initiatives and papers around but not restricted to: 1. Rejuvenation Therapies 2. Longevity Medicine 3. Regenerative Medicine 4. Health Tech, MediTech and BioTech 5. Precision Oncology 6. Molecular Biology 7. Biophilosophy 8. Transhumanism 9. Genomics 10. Metabolic Health and Precision 11. Longevity for Pets and Endangered Species 12. Aesthetics beyond Beauty 13. Bioinformatics 14. Biophysics 13. Pharamacogenomics, Pharamacognosy, and Pharmacovigilance 14. Health Economics and Health Policy Etc Joe Bardin, a visionary in the field describes ILSA as pioneering the pioneering. Expect thought-provoking talks that push boundaries. The call for papers is closing soon and tickets are selling fast. Don't miss out on this wonderful edition of ILSA! Visit: https://lnkd.in/dxx_dYEF Join us at ILSA 2024 and be part of the Afrolongevity revolution.

A comprehensive review on the impact of the #microenvironment and the significance of #MRD in #multiplemyeloma. Read it! DOI: 10.3390/ijms232415879